stockrowMaze Therapeutics, Inc. (MAZE) vs Stoke Therapeutics, Inc. (STOK)
- Maze Therapeutics, Inc. MAZE 34.19 +5.10%
- Stoke Therapeutics, Inc. STOK 26.54 +1.80%
Maze Therapeutics, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Maze Therapeutics, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.8B and $1.7B). Maze Therapeutics, Inc. has the higher net margin (0.00% vs −862.1%) and the higher return on invested capital (−112.4% vs −482.0%). Across the 13 metrics below, Maze Therapeutics, Inc. leads on 11 and Stoke Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | MAZE | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 68.51% |
| Operating margin | 0.00% | (913.12%) | 0.00% |
| Net margin | 0.00% | (862.07%) | 0.00% |
| Free cash flow margin | 0.00% | (764.66%) | 0.00% |
| Return on equity | (37.35%) | (73.62%) | (51.96%) |
| Return on assets | (31.99%) | (63.42%) | (46.06%) |
| Return on invested capital | (112.36%) | (482.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack